FZD5 mediates both canonical (β-catenin-dependent) and non-canonical Wnt signaling :
Embryogenesis: Regulates yolk sac angiogenesis and placental vascularization .
Neuronal Development: Promotes synapse formation and thalamic neuron survival .
Immune Regulation: Orchestrates adaptive immunity via microbial stimulus responses .
| Ligand | Activation Efficacy | Pathway Involved |
|---|---|---|
| Wnt5A | High | Canonical/Non-canonical |
| Wnt10B | Moderate | Canonical |
| Wnt7A | Moderate | Synaptogenesis |
| Wnt2B | None | – |
| Data from in vitro studies |
Inhibits Wnt-3a-induced alkaline phosphatase production in MC3T3-E1 cells (ED₅₀: 10–60 ng/ml) .
Used to map Wnt/Frizzled binding interfaces via competitive assays .
Cancer: Overexpressed in tumor vasculature; potential therapeutic target .
Inflammation: Modulates cytokine production in macrophages .
Binding Kinetics: Surface plasmon resonance (SPR) to quantify Wnt-FZD5 interactions .
Ubiquitination Studies: Degraded via RNF43/ZNRF3-mediated proteasomal pathways .
Structurally, Mouse Frizzled-5 is a G protein-coupled receptor consisting of several key domains: a divergent signal peptide, a highly conserved extracellular cysteine-rich domain (CRD), a variable-length linker region, a seven-pass transmembrane domain, and a variable-length C-terminal tail . The mature mouse Frizzled-5 protein contains a 212 amino acid extracellular domain (ECD), a 283 amino acid seven-transmembrane region, and a 64 amino acid cytoplasmic domain with a PDZ binding motif . This structure is characteristic of the Frizzled family, facilitating specific interactions with Wnt ligands and downstream signaling components.
Within the N-terminal extracellular domain (ECD), human Frizzled-5 shares 95% amino acid sequence identity with mouse and rat Frizzled-5, indicating high evolutionary conservation . This conservation is especially pronounced in the cysteine-rich region (CRD) that binds Wnts and is highly conserved among all Frizzled proteins . The high sequence homology suggests functional conservation and allows for meaningful translation of research findings between species, particularly in developmental and pathological contexts.
Mouse Frizzled-5 functions as a receptor for multiple Wnt ligands, including Wnt-5a, Wnt-9b, Wnt-10b, Wnt-2b, and Wnt-7a . The specificity of these interactions is determined primarily by the cysteine-rich domain (CRD) in the extracellular portion of the receptor. In functional assays, recombinant Mouse Frizzled-5 has been shown to inhibit Wnt-3a induced alkaline phosphatase production in MC3T3-E1 mouse preosteoblast cells, with an ED50 of 0.01-0.06 μg/ml . This diverse ligand-binding profile contributes to the broad functional roles of Frizzled-5 in different tissues and developmental contexts.
Frizzled-5 can activate both canonical Wnt/beta-catenin signaling and non-canonical pathways including Wnt/Ca2+ pathways and planar cell polarity . In canonical signaling, Wnt engagement of Frizzled, with low-density lipoprotein receptor-related proteins LRP-5 or LRP-6 acting as co-receptors, stabilizes beta-catenin and promotes gene transcription essential for development and tissue maintenance . Frizzleds can also signal through non-canonical pathways independently of LRPs . The specific pathway activated depends on the cellular context, the specific Wnt ligand, and the presence of co-receptors and intracellular signaling components.
Frizzled-5 is believed to be the primary receptor for the Wnt5A ligand and plays a crucial role in activating the JNK (c-Jun N-terminal kinase) signaling pathway . In pathological conditions such as heart failure, inhibition of the Wnt5A/JNK signaling pathway through interventions like SFRP5 (Secreted Frizzled-Related Protein 5) administration has shown protective effects . Research demonstrates that when SFRP5 recombinant protein is administered to mice with heart failure, it increases SFRP5 protein expression while decreasing Wnt5a and JNK protein expression levels . This mechanism appears to reduce oxidative stress and inflammation, suggesting potential therapeutic applications.
The cytoplasmic domain of Frizzled-5 contains a KTXXXW motif that mediates interaction with Dishevelled proteins, which are critical intracellular signal-transduction components . Additionally, PDZ-domain proteins like PSD-95 can interact with mouse Frizzled proteins including Fz1, Fz2, Fz4, and Fz7 . For Frizzled-3, a protein called Kermit interacts directly with the cytoplasmic domain and is recruited to the cell surface specifically by this receptor . While specific Kermit-like molecules for Frizzled-5 have not been fully characterized, these interaction patterns suggest complex signaling networks downstream of Frizzled receptors.
Frizzled-5 exhibits a diverse expression pattern across development and adulthood. In embryonic tissues, it is expressed in the telencephalon, pituitary, thalamus, hypothalamus, eye, liver, spleen, lung, and kidney . In adult tissues, Frizzled-5 expression is maintained in the retina, colon, and pancreatic islets . It is also expressed in some cancer cell lines, human embryonic stem cells, and specific immune cell populations including monocytes and lymphocytes . This broad expression pattern correlates with the diverse functions of Frizzled-5 in tissue development, maintenance, and response to pathological conditions.
Frizzled-5 plays a critical role in vascular development and maintenance. It contributes to the maintenance of yolk sac and placental vasculature during embryonic development . Additionally, it is involved in the regression of vitreous vasculature during eye development . Mutations in human FZD4, a related Frizzled family member, are associated with familial exudative vitreoretinopathy (FEVR), an inherited form of retinal degeneration with progressive hearing loss . These findings highlight the importance of Frizzled receptors in vascular development and homeostasis.
Frizzled-5 is essential for multiple aspects of neuronal development and function. It mediates the synaptogenic effect of Wnt-7a, contributes to the development of neuronal polarity, and is required for neuronal survival in the thalamus . Loss of Frizzled-5 function can lead to neuronal defects, particularly in regions where it is highly expressed during development, such as the telencephalon, thalamus, and hypothalamus . These functions highlight the importance of Wnt/Frizzled signaling in establishing proper neural connectivity and maintaining neuronal health.
Recombinant Mouse Frizzled-5 protein is typically provided in lyophilized form and should be reconstituted according to manufacturer specifications. For example, R&D Systems' Recombinant Mouse Frizzled-5 Fc Chimera Protein should be reconstituted at 500 μg/mL in PBS . After reconstitution, it's recommended to store the protein at the temperature recommended by the manufacturer (often -20°C) and avoid repeated freeze-thaw cycles to maintain protein stability and activity . For carrier-free versions without BSA, special handling considerations may apply when using the protein in applications where BSA could interfere with experimental outcomes.
Several functional assays can be employed to study Frizzled-5 activity:
These assays provide complementary information about Frizzled-5 function in different contexts and can be selected based on the specific research question being addressed.
Validation of recombinant Frizzled-5 protein should include both purity and functional assessments. Purity can be assessed using SDS-PAGE, with high-quality preparations typically showing >95% purity . Endotoxin levels should be measured (e.g., LAL test) and should be less than 0.01EU/μg purified protein for reliable experimental outcomes . Functional validation can include the alkaline phosphatase inhibition assay in MC3T3-E1 cells, with expected ED50 values between 0.01-0.06 μg/ml when inhibiting Wnt-3a (5 ng/mL) induced responses . Additionally, binding assays with known Wnt ligands can confirm proper folding and biological activity of the recombinant protein.
In heart failure models, dysregulation of Wnt5A/JNK signaling (which involves Frizzled-5 as a receptor) contributes to pathological processes. Studies using isoproterenol-induced heart failure in mice have shown that SFRP5 (Secreted Frizzled-Related Protein 5) recombinant protein has protective effects . After intraperitoneal injection of SFRP5 recombinant protein (0.02 mg/kg/24h) in mice with heart failure, researchers observed reduced inflammatory responses and improved left ventricular systolic and diastolic function . The mechanism appears to involve inhibition of the Wnt5A/JNK signaling pathway, reduction of oxidative stress, and attenuation of inflammation .
Frizzled-5 plays a significant role in inflammatory responses, particularly in macrophages and monocytes. Research has shown that Frizzled-5 signaling in these cells induces the production of inflammatory cytokines . Recent studies of WNT5A/Frizzled-5 signaling have revealed an unexpected and novel role in orchestrating adaptive immunity in response to microbial stimulation . This suggests that targeting Frizzled-5 signaling might offer therapeutic opportunities in inflammatory conditions. The interaction between SFRP5 and Frizzled-5 signaling also influences inflammatory processes, as demonstrated in heart failure models where SFRP5 administration reduced inflammatory cell infiltration in myocardial tissue .
Secreted Frizzled-Related Proteins (SFRPs), particularly SFRP5, modulate Frizzled-5 signaling by competing with Frizzled receptors for Wnt ligand binding. SFRP5 contains a cysteine-rich domain similar to the extracellular domain of Frizzled receptors, allowing it to sequester Wnt ligands and prevent their interaction with Frizzled-5 . In experimental models, administration of SFRP5 recombinant protein increases SFRP5 levels while decreasing Wnt5a and JNK protein expression . This modulation appears to have protective effects in pathological conditions such as heart failure, where SFRP5 treatment improves myocardial tissue structure and function by inhibiting the Wnt5A/JNK signaling pathway and reducing oxidative stress .
A significant controversy in Frizzled research concerns whether these receptors directly couple to G proteins for signal transduction. Despite their classification as G protein-coupled receptors (GPCRs), the exact mechanism of G protein coupling remains contested. As noted in the literature, "the exciting possibility that Frizzleds couple directly to G proteins is still a controversial area, perhaps in part because of the lack of genetic data to support the idea of this interaction" . This controversy has implications for understanding the precise mechanisms of both canonical and non-canonical Wnt signaling through Frizzled-5 and may influence the development of targeted therapeutics or experimental approaches.
Studying Frizzled-5 signaling specificity presents several methodological challenges:
Redundancy among Frizzled receptors and Wnt ligands complicates interpretation of knockout studies
Context-dependent signaling outcomes vary based on cell type and developmental stage
Distinguishing between canonical and non-canonical pathway activation requires specialized assays
Co-receptor involvement (e.g., LRP5/6) introduces additional variables
Researchers must employ multiple complementary approaches including genetic models, biochemical assays, and cell-based systems to fully characterize Frizzled-5 signaling specificity in different contexts.
Post-translational modifications likely play important roles in regulating Frizzled-5 function, though this area remains incompletely characterized. Glycosylation of the extracellular domain may affect ligand binding and receptor stability. Phosphorylation of intracellular domains could modulate interactions with downstream signaling partners including Dishevelled proteins and other PDZ-domain containing proteins . Additionally, ubiquitination may regulate receptor trafficking and turnover. Understanding these modifications presents both experimental challenges and opportunities for therapeutic intervention by targeting specific modified forms of the receptor.